Johnson & Johnson
This page as JSON
GET /v2/symbols/JNJGet a free API key ↗| 24 hours | 7 days | Whole window | |
|---|---|---|---|
| Statements | 39 | 52 | 78 |
| Stories | 20 | 31 | 53 |
| Outlets | 19 | 21 | 25 |
| ▲ Bullish | 20 | 24 | 42 |
| ▼ Bearish | 10 | 11 | 12 |
| ● Neutral | 9 | 17 | 24 |
Coverage, day by day
Tone of the statements
All 52 statements naming Johnson & Johnson, last 7 days
▲ 24 ▼ 11 ● 17
46 that name only Johnson & Johnson
▲ 22 ▼ 10 ● 14
A statement that also names others may not be about Johnson & Johnson; the second bar counts only those that name it alone. Tone is a label on each statement. It describes the news, not a price.
Latest statements
Johnson & Johnson received FDA approval for a new surgical robot tool
Johnson & Johnson beat adjusted earnings estimates
Johnson & Johnson's third-quarter revenue increased by 5.9% year over year.
Johnson & Johnson reported a 96% drop in benefits due to talc dust litigation.
Johnson & Johnson's medtech business slowed in the third quarter due to ongoing struggles in the Abiomed business.
5 of 78 statements shown. The API returns all of them: GET /v2/statements?symbol=JNJ Get a free API key ↗